Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katelyn M, Rossow"'
Autor:
Michelle Liu, Katelyn M. Rossow, Angela C. Maxwell‐Horn, Leigh Ann Saucier, Sara L. Van Driest
Publikováno v:
Pharmacotherapy.
Pharmacogenetic testing for psychiatry is growing at a rapid pace, with multiple sites utilizing results to help clinical decision-making. Genotype-guided dosing and drug selection have been implemented at several sites, including Vanderbilt Universi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35115fd1a55166070ceaaa4d167275c8
https://pubmed.ncbi.nlm.nih.gov/36524442
https://pubmed.ncbi.nlm.nih.gov/36524442
Publikováno v:
Pediatric Research. 91:529-538
This review evaluates the pediatric evidence for pharmacogenetic associations for drugs that are commonly prescribed by or encountered by pediatric clinicians across multiple subspecialties, organized from most to least pediatric evidence. We begin w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5683de3664655d1beb0a8c4b2aa54e4
https://doi.org/10.1038/s41390-021-01499-2
https://doi.org/10.1038/s41390-021-01499-2
Publikováno v:
Pharmacogenomics. 22(8)
Tweetable abstract High-quality studies examining the influence of CYP2D6 on the exposure and tolerability of antipsychotics in youth are needed to mitigate the limitations of prior studies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0be101cb68e0b25e37e93b8c2e803f
https://pubmed.ncbi.nlm.nih.gov/34032507
https://pubmed.ncbi.nlm.nih.gov/34032507
Publikováno v:
Pediatrics
OBJECTIVES: To determine the association between cytochrome P450 2C19 (CYP2C19) metabolizer status and risk for escitalopram and citalopram, collectively termed (es)citalopram, and sertraline adverse events (AEs) in children. METHODS: In this retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa98dfb34a206a2adda489fced07c0e
https://doi.org/10.1542/peds.2020-0957
https://doi.org/10.1542/peds.2020-0957
Publikováno v:
Pediatric research. 91(3)
This review evaluates the pediatric evidence for pharmacogenetic associations for drugs that are commonly prescribed by or encountered by pediatric clinicians across multiple subspecialties, organized from most to least pediatric evidence. We begin w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::510e002b4f8d95554284c8d7dfc036ad
https://pubmed.ncbi.nlm.nih.gov/33824446
https://pubmed.ncbi.nlm.nih.gov/33824446
Autor:
Dan M. Roden, Angela C. Maxwell-Horn, Sara L. Van Driest, Kazeem A Oshikoya, Katelyn M. Rossow, Ida Aka
Publikováno v:
J Dev Behav Pediatr
Objective To determine the association between genetic variants reported to affect risperidone and adverse events (AEs) in children and adolescents. Methods Individuals aged 18 years or younger with ≥4 weeks of risperidone exposure in a deidentifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460e8c09345f612bdb81d1442ba6794e
https://pubmed.ncbi.nlm.nih.gov/33759847
https://pubmed.ncbi.nlm.nih.gov/33759847